ADA 2017

ADA 2017

Structured Care Program May Ease Transition from Pediatric to Adult Care
Adolescents and young adults with type 1 diabetes benefit from a structured transition program when changing from pediatric to adult diabetes care.
Strong Cardio Safety Data for SGLT2 Inhibitor
These data, from the integrated analysis of the CANVAS and CANVAS-R trials, demonstrated the CV safety of canagliflozin (P<.0001 for non-inferiority) and superiority compared to placebo (P=.0158).
ODYSSEY-Diabetes Trial: Latest Results
Results of this trial were presented at the ADA Meeting in San Diego. 
Long-Term Metformin Drops Risk of Heart Disease in Adults with T1D?
Metformin may be an effective long-term strategy worthy of adding to an individual’s diabetes care plan to reduce the risk of heart disease in adults with type 1 diabetes.
Medication That Inhibits PCSK9 Reduced CVD Risk in T2D Patients
The results of the ODYSSEY-Diabetes trials focused on alirocumab, an approved monoclonal antibody that prevents PCSK-9 protein from impairing the liver’s receptors, and that antibody's effect on type 2 diabetes (T2D).
Work to Do Before Medicare's Diabetes Prevention Program Is Set in Place
While Medicare awaits its DPP rollout, it exists already through many outlets nationally. 
What Advice Could Help Patients Improve Their Insulin Adherence?
Insulin adherence was a hot topic this week at the ADA 2017 meeting.
 
Texting System Benefits Glycemic Control for Teens with Diabetes
Given the current landscape of cellphone use among teens, it is fitting to evaluate the potential impact of text message reminders aimed at assisting teens and young adults with their diabetes self-management. 
Overweight Boys Who Lose Weight Before Adulthood Reduce Type 2 Diabetes Risk
Boys who are overweight during childhood can normalize their weight as young adults to avoid diabetes.
Remain Aware of Type 2 Diabetes Risk in Youth, Especially in Children Who Are Severely Obese
Results of analysis emphasize importance of developing effective means of preventing or treating obesity in youth.
ADA Honors Diabetes Complication Research
Research of macrovascular complications in diabetes honored at American Diabetes Association’s 77th Scientific Sessions. 
ADA Recognizes Work in Gestational Diabetes
Gernot Desoye, PhD, was chosen to receive the American Diabetes Association (ADA) 2017 Norbert Freinkel Award, which honors the memory of Norbert Freinkel, who was a talented researcher and writer. 
American Diabetes Association Honors Contributions to Behavioral Care for Diabetes
Michael A. Harris, PhD, has been awarded with the American Diabetes Association (ADA) 2017 Richard R. Rubin Award, which recognizes a researcher who has made significant contributions to understanding the behavioral components of diabetes treatment.
Study Finds Youth With Type 1 Diabetes Have Increased PCSK9
The enzyme that affects the body's ability to process LDL cholesterol was found to be correlated with A1C levels. A symposium on the topic will be part of this weekend's 77th Scientific Sessions of the American Diabetes Association.
American Diabetes Association, Walmart Team Up for 'Wellness Day'
The largest health fair in America will once again be coming to communities across the country. During Wellness Day on June 17, Walmart will offer free health screenings in its more than 4,600 locations across the country, from 10 a.m. to 2 p.m. local time.
American Diabetes Association Meeting Kicks Off This Weekend
The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego this weekend, June 9 through June 13, and Pharmacy Times will bring you all the latest diabetes news from this meeting. 
 

A Fast, Easy Way to Inform Parents About Vaccinations

Officials with the Centers for Disease Control and Prevention have prepared an informational video on this topic.

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.